

Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
The global Exosome Manufacturing Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Exosome Manufacturing Service Industry Forecast” looks at past sales and reviews total world Exosome Manufacturing Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Manufacturing Service sales for 2023 through 2029. With Exosome Manufacturing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Manufacturing Service industry.
This Insight Report provides a comprehensive analysis of the global Exosome Manufacturing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Manufacturing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Manufacturing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Manufacturing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Manufacturing Service.
United States market for Exosome Manufacturing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Manufacturing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Manufacturing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Manufacturing Service players cover Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Manufacturing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Human Embryonic Kidney Cell-Derived Exosomes
Bone Marrow Stem Cell-Derived Exosomes
Immature Dendritic Cell-Derived Exosomes
Milk-Derived Exosomes
Red Blood Cell-Derived Exosomes
Others
Segmentation by Application:
Laboratory
Pharmaceutical Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Human Embryonic Kidney Cell-Derived Exosomes
Bone Marrow Stem Cell-Derived Exosomes
Immature Dendritic Cell-Derived Exosomes
Milk-Derived Exosomes
Red Blood Cell-Derived Exosomes
Others
Segmentation by Application:
Laboratory
Pharmaceutical Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Guidon (Beijing) Pharmaceutical Technology
Cytoniche
EverZom
Lonza
RoosterBio
SBI
Creative-Biolabs
Esco Aster
EXO Biologics
Eppendorf
Aethlon Medical
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exosome Manufacturing Service Market Size 2019-2030
2.1.2 Exosome Manufacturing Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Exosome Manufacturing Service by Country/Region, 2019, 2023 & 2030
2.2 Exosome Manufacturing Service Segment by Type
2.2.1 Human Embryonic Kidney Cell-Derived Exosomes
2.2.2 Bone Marrow Stem Cell-Derived Exosomes
2.2.3 Immature Dendritic Cell-Derived Exosomes
2.2.4 Milk-Derived Exosomes
2.2.5 Red Blood Cell-Derived Exosomes
2.2.6 Others
2.3 Exosome Manufacturing Service Market Size by Type
2.3.1 Exosome Manufacturing Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Manufacturing Service Market Size Market Share by Type (2019-2024)
2.4 Exosome Manufacturing Service Segment by Application
2.4.1 Laboratory
2.4.2 Pharmaceutical Companies
2.4.3 Others
2.5 Exosome Manufacturing Service Market Size by Application
2.5.1 Exosome Manufacturing Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Manufacturing Service Market Size Market Share by Application (2019-2024)
3 Exosome Manufacturing Service Market Size by Player
3.1 Exosome Manufacturing Service Market Size Market Share by Player
3.1.1 Global Exosome Manufacturing Service Revenue by Player (2019-2024)
3.1.2 Global Exosome Manufacturing Service Revenue Market Share by Player (2019-2024)
3.2 Global Exosome Manufacturing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Manufacturing Service by Region
4.1 Exosome Manufacturing Service Market Size by Region (2019-2024)
4.2 Global Exosome Manufacturing Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Exosome Manufacturing Service Market Size Growth (2019-2024)
4.4 APAC Exosome Manufacturing Service Market Size Growth (2019-2024)
4.5 Europe Exosome Manufacturing Service Market Size Growth (2019-2024)
4.6 Middle East & Africa Exosome Manufacturing Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Exosome Manufacturing Service Market Size by Country (2019-2024)
5.2 Americas Exosome Manufacturing Service Market Size by Type (2019-2024)
5.3 Americas Exosome Manufacturing Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Manufacturing Service Market Size by Region (2019-2024)
6.2 APAC Exosome Manufacturing Service Market Size by Type (2019-2024)
6.3 APAC Exosome Manufacturing Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Manufacturing Service Market Size by Country (2019-2024)
7.2 Europe Exosome Manufacturing Service Market Size by Type (2019-2024)
7.3 Europe Exosome Manufacturing Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Manufacturing Service by Region (2019-2024)
8.2 Middle East & Africa Exosome Manufacturing Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Manufacturing Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Exosome Manufacturing Service Market Forecast
10.1 Global Exosome Manufacturing Service Forecast by Region (2025-2030)
10.1.1 Global Exosome Manufacturing Service Forecast by Region (2025-2030)
10.1.2 Americas Exosome Manufacturing Service Forecast
10.1.3 APAC Exosome Manufacturing Service Forecast
10.1.4 Europe Exosome Manufacturing Service Forecast
10.1.5 Middle East & Africa Exosome Manufacturing Service Forecast
10.2 Americas Exosome Manufacturing Service Forecast by Country (2025-2030)
10.2.1 United States Market Exosome Manufacturing Service Forecast
10.2.2 Canada Market Exosome Manufacturing Service Forecast
10.2.3 Mexico Market Exosome Manufacturing Service Forecast
10.2.4 Brazil Market Exosome Manufacturing Service Forecast
10.3 APAC Exosome Manufacturing Service Forecast by Region (2025-2030)
10.3.1 China Exosome Manufacturing Service Market Forecast
10.3.2 Japan Market Exosome Manufacturing Service Forecast
10.3.3 Korea Market Exosome Manufacturing Service Forecast
10.3.4 Southeast Asia Market Exosome Manufacturing Service Forecast
10.3.5 India Market Exosome Manufacturing Service Forecast
10.3.6 Australia Market Exosome Manufacturing Service Forecast
10.4 Europe Exosome Manufacturing Service Forecast by Country (2025-2030)
10.4.1 Germany Market Exosome Manufacturing Service Forecast
10.4.2 France Market Exosome Manufacturing Service Forecast
10.4.3 UK Market Exosome Manufacturing Service Forecast
10.4.4 Italy Market Exosome Manufacturing Service Forecast
10.4.5 Russia Market Exosome Manufacturing Service Forecast
10.5 Middle East & Africa Exosome Manufacturing Service Forecast by Region (2025-2030)
10.5.1 Egypt Market Exosome Manufacturing Service Forecast
10.5.2 South Africa Market Exosome Manufacturing Service Forecast
10.5.3 Israel Market Exosome Manufacturing Service Forecast
10.5.4 Turkey Market Exosome Manufacturing Service Forecast
10.6 Global Exosome Manufacturing Service Forecast by Type (2025-2030)
10.7 Global Exosome Manufacturing Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Exosome Manufacturing Service Forecast
11 Key Players Analysis
11.1 Guidon (Beijing) Pharmaceutical Technology
11.1.1 Guidon (Beijing) Pharmaceutical Technology Company Information
11.1.2 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Offered
11.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Guidon (Beijing) Pharmaceutical Technology Main Business Overview
11.1.5 Guidon (Beijing) Pharmaceutical Technology Latest Developments
11.2 Cytoniche
11.2.1 Cytoniche Company Information
11.2.2 Cytoniche Exosome Manufacturing Service Product Offered
11.2.3 Cytoniche Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Cytoniche Main Business Overview
11.2.5 Cytoniche Latest Developments
11.3 EverZom
11.3.1 EverZom Company Information
11.3.2 EverZom Exosome Manufacturing Service Product Offered
11.3.3 EverZom Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 EverZom Main Business Overview
11.3.5 EverZom Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Exosome Manufacturing Service Product Offered
11.4.3 Lonza Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 RoosterBio
11.5.1 RoosterBio Company Information
11.5.2 RoosterBio Exosome Manufacturing Service Product Offered
11.5.3 RoosterBio Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 RoosterBio Main Business Overview
11.5.5 RoosterBio Latest Developments
11.6 SBI
11.6.1 SBI Company Information
11.6.2 SBI Exosome Manufacturing Service Product Offered
11.6.3 SBI Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 SBI Main Business Overview
11.6.5 SBI Latest Developments
11.7 Creative-Biolabs
11.7.1 Creative-Biolabs Company Information
11.7.2 Creative-Biolabs Exosome Manufacturing Service Product Offered
11.7.3 Creative-Biolabs Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Creative-Biolabs Main Business Overview
11.7.5 Creative-Biolabs Latest Developments
11.8 Esco Aster
11.8.1 Esco Aster Company Information
11.8.2 Esco Aster Exosome Manufacturing Service Product Offered
11.8.3 Esco Aster Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Esco Aster Main Business Overview
11.8.5 Esco Aster Latest Developments
11.9 EXO Biologics
11.9.1 EXO Biologics Company Information
11.9.2 EXO Biologics Exosome Manufacturing Service Product Offered
11.9.3 EXO Biologics Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 EXO Biologics Main Business Overview
11.9.5 EXO Biologics Latest Developments
11.10 Eppendorf
11.10.1 Eppendorf Company Information
11.10.2 Eppendorf Exosome Manufacturing Service Product Offered
11.10.3 Eppendorf Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eppendorf Main Business Overview
11.10.5 Eppendorf Latest Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Information
11.11.2 Aethlon Medical Exosome Manufacturing Service Product Offered
11.11.3 Aethlon Medical Exosome Manufacturing Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Aethlon Medical Main Business Overview
11.11.5 Aethlon Medical Latest Developments
12 Research Findings and Conclusion
*If Applicable.